SCHEDULE: Sherpa Healthcare Funds Increase Stake in Alamar Biosciences
Beneficial Ownership Filing
Sherpa Healthcare Fund II, L.P. and Sherpa Healthcare Co-Investment Fund, L.P., along with Daqing Cai, have reported beneficial ownership of 7.2% of Alamar Biosciences, Inc. common stock.
Summary
- Sherpa Healthcare Fund II, L.P. now beneficially owns 3,970,446 shares of Alamar Biosciences, Inc. common stock, representing 5.7% of the class.
- Sherpa Healthcare Co-Investment Fund, L.P. now beneficially owns 1,001,688 shares of Alamar Biosciences, Inc. common stock, representing 1.4% of the class.
- Daqing Cai, as Managing Director of the general partners of these funds, may be deemed to have shared voting and dispositive control over these shares.
- Collectively, the reporting persons hold an aggregate of 4,972,134 shares, representing 7.2% of the outstanding common stock.
- The total number of outstanding shares of common stock as of April 30, 2026, was 69,311,186.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing as it reports on ownership changes rather than company performance or strategic shifts. The increased stake by Sherpa Healthcare Funds suggests positive sentiment from these investors, but the filing itself is purely informational.
Positives
- Increased beneficial ownership reported by Sherpa Healthcare Funds, indicating continued investment conviction.
- Combined stake of 7.2% suggests a significant position in Alamar Biosciences, Inc.
Future Outlook
This filing is a Schedule 13G, which reports beneficial ownership and does not contain forward-looking statements or guidance from the company itself. The reporting persons' future actions regarding their stake are not disclosed.
Industry Context
StockSavvy.ai notes that this Schedule 13G filing indicates a significant investment by Sherpa Healthcare Funds in Alamar Biosciences, Inc. Such filings often precede or follow strategic developments, and an increased stake by institutional investors can signal confidence in the company's prospects within the biotechnology or diagnostics sector.
Stakeholder Impact
- Shareholders: The increased stake by Sherpa Healthcare Funds may be interpreted as a positive signal of institutional confidence, potentially influencing market perception.
- Company Management: The filing confirms a significant ownership position held by Sherpa Healthcare, which may influence future board composition or strategic discussions.
Key Dates
| Date | Description |
|---|---|
| 2026-04-30 | Date as of which the total number of shares of common stock of the Issuer issued and outstanding was reported. |
| 2026-05-08 | Date of filing of the Issuer's Form 10-Q reporting the outstanding shares. |
| 2026-04-16 | Date of Event Which Requires Filing of this Statement (Schedule 13G filing date). |
| 2026-07-02 | Date of certification for the Schedule 13G filing. |
Keywords
Alamar Biosciences, Sherpa Healthcare Fund, Schedule 13G, Beneficial Ownership, Common Stock, Investment, Cayman Islands, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.